ENRAYZA Trademark

Trademark Overview

On Friday, July 15, 2022, a trademark application was filed for ENRAYZA with the United States Patent and Trademark Office. The USPTO has given the ENRAYZA trademark a serial number of 97505394. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by Aytu BioPharma, Inc.. The ENRAYZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of connective tissue disorders
enrayza

General Information

Serial Number97505394
Word MarkENRAYZA
Filing DateFriday, July 15, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of connective tissue disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAytu BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDenver, CO 80237
Party NameAytu BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEnglewood, CO 80129

Trademark Events

Event DateEvent Description
Tuesday, July 19, 2022NEW APPLICATION ENTERED
Thursday, August 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 1, 2023ASSIGNED TO EXAMINER
Thursday, May 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024SOU EXTENSION 1 FILED
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, March 7, 2024PETITION TO REVIVE-GRANTED
Thursday, March 7, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, March 7, 2024NOTICE OF REVIVAL - E-MAILED
Monday, April 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, March 7, 2024TEAS PETITION TO REVIVE RECEIVED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Thursday, April 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 17, 2024SOU EXTENSION 1 GRANTED

Related Keywords

enrayza tissue disorders connective treatment preparations pharmaceutical